title: [Plasmapheresis in the treatment of cytostatic disease in patients with lymphogranulomatosis].
authors.forename: S A
authors.initials: SA
authors.lastname: Belkov
authors.forename: V I
authors.initials: VI
authors.lastname: Andriukhin
authors.forename: V B
authors.initials: VB
authors.lastname: Korsakov
authors.forename: V F
authors.initials: VF
authors.lastname: Pugachev
authors.forename: E A
authors.initials: EA
authors.lastname: Riazantsev
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000528:radiation effects*; D008231:Lymphopenia / Q000209:etiology / Q000628:therapy*; D008297:Male; D010956:Plasmapheresis; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011832:Radiation Injuries / Q000150:complications*; D011882:Radiotherapy, High-Energy / Q000009:adverse effects*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone
vernacular_title: Plazmaferez v lechenii tsitostaticheskoĭ bolezni u bol'nykh limfogranulomatozom.